Lincoln Alternative Strategies LLC - 18 Sep 2025 SCHEDULE 13G/A Report for Calidi Biotherapeutics, Inc. Common stock, par value $0.0001 per share (CLDI)

Filing Manager: Lincoln Alternative Strategies LLC
Reporting Manager: Lincoln Alternative Strategies LLC
Security: Calidi Biotherapeutics, Inc. Common stock, par value $0.0001 per share
Symbol: CLDI
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13G/A
Filing time: 10 Feb 2026, 14:08:21 UTC
Date of event: 18 Sep 2025
Previous filing: 27 Aug 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Lincoln Alternative Strategies LLC	0%	0	0	0	/s/ Stephen Temes	Stephen Temes/Managing Member